The power of perseverance - how Dendreon bounced back
23 Jan 2019
- Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy.
- Dendreon’s flagship product, PROVENGE (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells.
- While the journey, which began in 1992, has been filled with many ups and downs, three ingredients to this company’s success has remained constant, it’s employees’:
1) resilience in the face of adversity,
2) attitude to make the fight against cancer personal, and
) perseverance to master the skills our patients count on each and every day.